S

SugenTech Inc
KOSDAQ:253840

Watchlist Manager
SugenTech Inc
KOSDAQ:253840
Watchlist
Price: 5 950 KRW 2.06% Market Closed
Market Cap: ₩99.6B

Operating Margin

-237.1%
Current
Improving
by 3.8%
vs 3-y average of -240.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-237.1%
=
Operating Income
₩-21.4B
/
Revenue
₩9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-237.1%
=
Operating Income
₩-21.4B
/
Revenue
₩9B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
SugenTech Inc
KOSDAQ:253840
91B KRW
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

Lower than 96% of companies in Korea
Percentile
4rd
Based on 2 615 companies
4rd percentile
-237.1%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

SugenTech Inc
Glance View

Market Cap
99.6B KRW
Industry
Health Care

Sugentech, Inc. develops in-vitro diagnostic systems and products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2016-11-11. The firm is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The firm distributes its products within the domestic market and to overseas markets, including Indonesia.

SugenTech Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-237.1%
=
Operating Income
₩-21.4B
/
Revenue
₩9B
What is SugenTech Inc's current Operating Margin?

The current Operating Margin for SugenTech Inc is -237.1%, which is above its 3-year median of -240.9%.

How has Operating Margin changed over time?

Over the last 3 years, SugenTech Inc’s Operating Margin has decreased from 49.5% to -237.1%. During this period, it reached a low of -635.7% on Sep 30, 2023 and a high of 49.5% on Aug 30, 2022.

Back to Top